Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?

por Luzum, Jasmine A., Lanfear, David E.
Publicado 2016

BNP and Precision Medicine: Tip of an Iceberg

por Lanfear, David E., Luzum, Jasmine A.
Publicado 2021

Joint Impact of Clinical and Behavioral Variables on the Risk of Unplanned Readmission and Death after a Heart Failure Hospitalization

por Padhukasahasram, Badri, Reddy, Chandan K., Li, Yan, Lanfear, David E.
Publicado 2015

Comparing methods for identifying patients with heart failure using electronic data sources

por Alqaisi, Fadi, Williams, L Keoki, Peterson, Edward L, Lanfear, David E
Publicado 2009

Initial High Sensitivity Troponin I Values Predict 28 Day Survival in Coronavirus-19 Patients

por Cook, Bernard, Lanfear, David E., Jacobsen, Gordon, Moyer, Michele, Nowak, Richard M., Linoj, Samuel
Publicado 2023

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide

por Sabbah, Hani N., Gupta, Ramesh C., Singh-Gupta, Vinita, Zhang, Kefei, Lanfear, David E.
Publicado 2018

A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction

por Lanfear, David E., Neaton, Kelsey R., Lu, Chen, Liu, Yimeng, Dent-Acosta, Ricardo E.
Publicado 2020

Factors influencing patient willingness to participate in genetic research after a myocardial infarction

por Lanfear, David E, Jones, Philip G, Cresci, Sharon, Tang, Fengming, Rathore, Saif S, Spertus, John A
Publicado 2011

Predicting death from COVID-19 using pre-existing conditions: implications for vaccination triage

por Xiao, Shujie, Sahasrabudhe, Neha, Hochstadt, Samantha, Cabral, Whitney, Simons, Samantha, Yang, Mao, Lanfear, David E, Williams, L Keoki
Publicado 2021

Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure

por Lanfear, David E, Hasan, Reema, Gupta, Ramesh C, Williams, Celeste, Czerska, Barbara, Tita, Cristina, Bazari, Rasha, Sabbah, Hani N
Publicado 2009

Single-Cell RNA Sequencing of the Cardiovascular System: New Looks for Old Diseases

por Chaudhry, Farhan, Isherwood, Jenna, Bawa, Tejeshwar, Patel, Dhruvil, Gurdziel, Katherine, Lanfear, David E., Ruden, Douglas M., Levy, Phillip D.
Publicado 2019

Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction

por Depta, Jeremiah P., Lenzini, Petra A., Lanfear, David E., Wang, Tracy Y., Spertus, John A., Bach, Richard G., Cresci, Sharon
Publicado 2014

Genetics of heart rate in heart failure patients (GenHRate)

por Evans, Kaleigh L., Wirtz, Heidi S., Li, Jia, She, Ruicong, Maya, Juan, Gui, Hongsheng, Hamer, Andrew, Depre, Christophe, Lanfear, David E.
Publicado 2019

Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF

por Pan, Guodong, Roy, Bipradas, Giri, Shailendra, Lanfear, David E., Thandavarayan, Rajarajan A., Guha, Ashrith, Ortiz, Pablo A., Palaniyandi, Suresh Selvaraj
Publicado 2022

The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial

por Spertus, John A., Birmingham, Mary C., Nassif, Michael, Damaraju, C. V., Abbate, Antonio, Butler, Javed, Lanfear, David E., Lingvay, Ildiko, Kosiborod, Mikhail N., Januzzi, James L.
Publicado 2022

Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups

por Padhukasahasram, Badri K., Yang, James J., Levin, Albert M., Yang, Mao, Burchard, Esteban G., Kumar, Rajesh, Kwok, Pui-Yan, Seibold, Max A., Lanfear, David E., Williams, L. Keoki
Publicado 2014

Race and Beta‐Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self‐Reported Race and Proportion of African Genetic Ancestry

por Luzum, Jasmine A., Peterson, Edward, Li, Jia, She, Ruicong, Gui, Hongsheng, Liu, Bin, Spertus, John A., Pinto, Yigal M., Williams, L. Keoki, Sabbah, Hani N., Lanfear, David E.
Publicado 2018

Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction

por Luzum, Jasmine A., Campos-Staffico, Alessandra M., Li, Jia, She, Ruicong, Gui, Hongsheng, Peterson, Edward L., Liu, Bin, Sabbah, Hani N., Donahue, Mark P., Kraus, William E., Williams, L. Keoki, Lanfear, David E.
Publicado 2023

Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditions

por Findley, Anthony S, Monziani, Alan, Richards, Allison L, Rhodes, Katherine, Ward, Michelle C, Kalita, Cynthia A, Alazizi, Adnan, Pazokitoroudi, Ali, Sankararaman, Sriram, Wen, Xiaoquan, Lanfear, David E, Pique-Regi, Roger, Gilad, Yoav, Luca, Francesca
Publicado 2021

Asthma and its relationship to mitochondrial copy number: Results from the Asthma Translational Genomics Collaborative (ATGC) of the Trans-Omics for Precision Medicine (TOPMed) pro...

por Cocco, Maxwell P., White, Evan, Xiao, Shujie, Hu, Donglei, Mak, Angel, Sleiman, Patrick, Yang, Mao, Bobbitt, Kevin R., Gui, Hongsheng, Levin, Albert M., Hochstadt, Samantha, Whitehouse, Kyle, Rynkowski, Dean, Barczak, Andrea J., Abecasis, Gonçalo, Blackwell, Thomas W., Kang, Hyun Min, Nickerson, Deborah A., Germer, Soren, Ding, Jun, Lanfear, David E., Gilliland, Frank, Gauderman, W. James, Kumar, Rajesh, Erle, David J., Martinez, Fernando, Hakonarson, Hakon, Burchard, Esteban G., Williams, L. Keoki
Publicado 2020